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This journal is ª The Royal Society ofDiscovery of a family of g-aminobutyrate ureas via
rational derepression of a silent bacterial gene cluster†
John D. Sidda,ab Lijiang Song,a Vincent Poon,ab Mahmoud Al-Bassam,c Orestis Lazos,a
Mark J. Buttner,c Gregory L. Challisa and Christophe Corre*ab
Gaburedins, a family of g-aminobutyrate (GABA)-derived ureas, have been discovered by deletion of gbnR,
an arpA-like putative transcriptional repressor in Streptomyces venezuelae ATCC 10712. Comparison of
metabolite proﬁles in the wild type and mutant strains revealed six metabolites in the mutant that are
lacking from the wild type. The structure of gaburedin A was established by HRMS combined with
1- and 2-D NMR spectroscopy and was conﬁrmed by total synthesis. The other metabolites were
conﬁrmed as congeners using HRMS, MS/MS and feeding of putative biosynthetic precursors. Two
genes, gbnA and gbnB, are proposed to be involved in gaburedin biosynthesis. Consistent with this
hypothesis, deletion of gbnB in the gbnR mutant abolished gaburedin production. This is the ﬁrst report
to disclose the discovery of novel natural products via rational deletion of a putative pathway-speciﬁc
regulatory gene.Streptomyces are soil-dwelling, lamentous bacteria that
produce a remarkably diverse range of bioactive natural prod-
ucts. Such molecules nd use in the treatment of infectious
diseases, cancer and transplant rejection, as well as in agricul-
ture. Indeed, almost 70% of commercially-available antibiotics
originate from the Streptomyces genus.1 Classical methods for
identication of novel natural products have focused on
screening cultures for specic bioactivities. However, these
approaches oen result in the re-discovery of known
compounds. Alternative strategies are therefore required for the
discovery of novel bioactive natural products from microbial
sources.2
The recent explosion in the availability of bacterial genome
sequences has led to the identication of many cryptic natural
product biosynthetic gene clusters.3 These oﬀer a promising
resource for novel natural product discovery.3 However, many
cryptic biosynthetic gene clusters are expressed poorly or not at
all under laboratory growth conditions.4,5 Rational approaches
are therefore required to induce the expression of such silent
biosynthetic pathways.
In addition to biosynthetic and self-resistance genes, single
or multiple genes encoding transcriptional regulators (activa-
tors or repressors) are typically present in bacterial natural
product biosynthetic gene clusters.5 Recently, it has beenarwick, Coventry, CV4 7AL, UK. E-mail:
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Chemistry 2013reported that the constitutive expression of a putative pathway-
specic transcriptional activator results in the production of a
novel complex of macrolide antibiotics by S. ambofaciens.4 A
similar strategy has been employed in Aspergillus nidulans to
discover the product of a cryptic biosynthetic pathway.6 Dele-
tion of putative bacterial pathway-specic transcriptional
repressors has been investigated as a complementary approach,
but has yet to result in the discovery of novel metabolites.7,8
ArpA-like transcriptional repressors belong to the TetR-family of
DNA-binding proteins and are known to control the production
of a wide variety of antibiotics.9,10 ArpA itself controls the
production of streptomycin in Streptomyces griseus.11 The
biosynthesis of several other natural products is repressed by
ArpA-like proteins and inactivation of arpA-like genes generally
boosts production levels, e.g. deletion of mmyR in Streptomyces
coelicolor has been shown to result in the overproduction of
methylenomycin antibiotics.12
ArpA-like proteins have been shown to sense and respond to
specic ligands such as g-butyrolactones, 2-alkyl-4-hydrox-
ymethylfuran-3-carboxylic acids (AHFCAs) and butenolides.13–17
In particular, the methylenomycin furans, assembled by the
products of the mmfLHP genes, act as methylenomycin
production inducers in S. coelicolor. These signaling molecules
are thought to interact with the ArpA-like transcriptional
repressors MmfR and/or MmyR.12,14 Even though MmfR and
MmyR share 35% identity and 56% similarity, the phenotypes
of mmfR and mmyR mutants are distinct. The strain lacking
mmyR overproduces the methylenomycin antibiotics, whereas
the strain lackingmmfR exhibits a phenotype similar to the wild
type strain.12Chem. Sci.
Fig. 2 LC-MS analysis of S. venezuelae gbnR mutant (blue trace), wild type (red
trace) and gbnR/gbnB double mutant (green trace) strains. Extracted ion chro-
matograms for m/z ¼ 246.9 (gaburedin D, 4); 260.9 (gaburedin B/C, 2/3); 279.0
(gaburedin F, 6); 292.9 (gaburedin E, 5); and 294.9 (gaburedin A, 1) are shown,
highlighting the metabolites identiﬁed in the gbnR mutant that are absent from
the wild type and double mutant strains.
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View Article OnlineBLAST searches revealed that several Streptomyces genomes
contain a cassette of ve genes homologous to mmfR–mmfLHP–
mmyR. These are proposed to be involved in the transcriptional
regulation of specic natural product biosynthetic pathways.14
Thus, inactivation of the mmyR homologues in these genomes
was predicted to result in induction of the biosynthetic gene
clusters under their control and biosynthesis of the corre-
sponding metabolic products.
The genome sequence of Streptomyces venezuelae ATCC
10712 became publicly available in 2012, revealing a cluster of
genes that contains the mmyR homologue gbnR (sven_4187), as
well as the mmfR homologue sgnR (sven_4182) and the mmfLHP
homologues sgnLPH (sven_4183, 4185 and 4188; Fig. 1). This
putative regulatory system is located adjacent to gbnABC
(sven_4179–4181), which encode potential natural product
biosynthetic and export proteins.
In silico analysis of the gbn gene cluster revealed highly
conserved DNA sequences in the sgnR-sgnL and gbnR-sgnH
intergenic regions as well as in the promoter region of gbnA
(Fig. 1). These conserved DNA sequences are proposed to be
binding sites for GbnR (Fig. 1). As a consequence, GbnR was
predicted to act as a repressor of the gbnABC operon, which
should therefore be constitutively expressed if gbnR is deleted.
Here we report that inactivation of gbnR in S. venezuelae
induces production of the gaburedins, a novel family of
g-aminobutyrate ureas. To the best of our knowledge, this is the
rst example of the discovery of a novel family of bacterial
natural products via rational manipulation of a putative
pathway-specic repressor gene.
The S. venezuelae gbnR::apr mutant was constructed using
PCR-targeting (see ESI†).18 The gbnR::apr and wild type strains
were grown on a supplemented minimal agar medium for 3
days, aer which the acidied agar medium was extracted with
ethyl acetate. The extracts were dried and re-suspended in
water–methanol (1:1). Metabolites produced by the wild type
andmutant strains were analysed by high resolution LC-MS/MS.
Comparison of the base peak chromatograms revealed six
metabolites (1–6), named gaburedins, which were produced by
the gbnR::apr mutant strain but not the wild type strain (Fig. 2).Fig. 1 Organisation of the gbn/sgn gene cluster (9.2 kb) that regulates and
directs gaburedin production in S. venezuelae ATCC 10712 and proposed func-
tions of the encoded proteins.
Chem. Sci.The molecular formulae of the metabolites were deduced to
be C14H18N2O5 for 1, C11H20N2O5 for 2 and 3, C10H18N2O5 for 4,
C10H16N2O6S for 5 and C10H18N2O5S for 6. A neutral loss of 129
Da was observed for each parent ion in the MS/MS spectrum,
corresponding to loss of a common C5H7NO3 fragment (Fig. 3).
Interestingly, the molecular formulae of the resulting
daughter ions matched those of the protonated amino acids
phenylalanine, isoleucine/leucine, valine and methionine for
compounds 1, 2/3, 4 (Fig. 5) and 6 respectively. For compound 5,
the molecular formulae for the daughter ion matched that of
acetylcysteine (C5H10NO3S). A further loss of a 42 Da fragment
from this daughter ion was consistent with the presence of an
acetyl group. An analogous fragmentation pattern was observed
for the [M + Na]+ ions of each gaburedin.
Cultures of the gbnR::apr mutant were scaled up to isolate
suﬃcient quantities of 1 for structure elucidation by NMR
spectroscopy (Fig. 4). COSY and HMBC experiments allowed
unambiguous elucidation of the planar structure. An authentic
standard of S-1 was synthesised via modication of the route
reported by Tayaka and co-workers for the synthesis of ureido-
containing derivatives of 5-uorouracil (Fig. 4).19 LC-MS/MSFig. 3 High resolution MS data for gaburedin D (4), C (3), B (2) and A (1) (top
panel to bottom panel, respectively), highlighting the neutral loss of 129 Da
observed for all gaburedins.
This journal is ª The Royal Society of Chemistry 2013
Fig. 5 Structures of gaburedins A–D (1–4) isolated from the S. venezuelae
gbnR::aprmutant, showing the conserved GABA fragment (boxed) common to all
gaburedins.
Fig. 4 Structure elucidation and total synthesis of gaburedin A 1. Bold lines
represent COSY correlations and arrows represent HMBC correlations observed
for the sample of 1 isolated from S. venezuelae.
Scheme 1 Proposed pathways for gaburedin biosynthesis.
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View Article Onlineand NMR analyses conrmed that the compound puried from
the gbnR::apr mutant strain was identical to the synthetic
standard 1.
Supplementation of the culture medium with specic amino
acids was found to inuence gaburedin production. For
example, growth of the gbnR::apr mutant in a culture medium
enriched in L-phenylalanine (20 mM nal concentration)
resulted in overproduction of gaburedin A 1 relative to the other
gaburedin congeners. Feeding with D-phenylalanine resulted in
the overproduction of a gaburedin with same retention time
and fragmentation pattern as 1. However, chiral HPLC analysis
indicated that this compound was the enantiomer of 1, con-
rming that the absolute conguration of 1 initially isolated
from S. venezuelae is S (ESI†).
The gbnR::apr mutant was grown in culture media supple-
mented with either L-isoleucine or L-leucine (20 mM nal
concentration) to distinguish between gaburedin B 2 and
gaburedin C 3 which have very similar retention times (Fig. 2).
The resulting culture extracts were analysed by LC-MS/MS,
revealing that the quantity of 3 increased dramatically when L-
isoleucine was fed, whereas the quantity of 2 signicantly
increased in the culture extract obtained from the mutant
grown in the presence of L-leucine (see ESI†). Specic incorpo-
ration of d10-leucine into 2 and d10-isoleucine into 3 further
conrmed the structural identity of these metabolites (ESI†).
Similarly the gbnR::aprmutant strain was grown in the presence
of N-acetylcysteine, in which case gaburedin E 5 was over-
produced. Further precursor-directed biosynthesis experiments
were carried out by supplementing the culture medium withThis journal is ª The Royal Society of Chemistry 2013various amino acids and gaburedins containing Val, Met, Tyr,
Trp, Gly, Ala, Pro, Ser, Thr and Glu were identied by LC-MS
analyses (see ESI†). The molecular formulae, fragmentation
patterns and retention times were all consistent with the
proposed structures (see ESI†). Interestingly supplementation
with g-aminobutyrate (GABA) resulted in the production of a
GABA dimer (7), in which the two monomers are linked by a
ureido bridge (molecular formulae C9H16N2O5, Scheme 1).
Amino acid analogues lacking the carboxylic acid group were
also incorporated into gaburedin analogues, e.g. isobutylamine
was found to elicit the production of compound 8 (Scheme 1).
The gbnA gene encodes a putative pyridoxal phosphate (PLP)-
dependent amino acid decarboxylase (Fig. 1), which is proposed
to decarboxylate glutamate to give GABA (Scheme 1). Interest-
ingly, feeding of the S. venezuelae gbnR mutant with glutamate
not only yielded the glutamate-derived gaburedin analogue but
also analogue 7, consistent with the hypothesis that GABA is
derived from decarboxylation of glutamate. The gbnB gene
encodes a putative ATP-dependent enzyme belonging to the
acyl-CoA synthetase superfamily (Fig. 1). GbnB is proposed to
adenylate either the carboxyl or the carbamoyl group of
compound 9, which derives from the spontaneous reaction of
GABA with CO2 (Scheme 1). Carboxyl adenylate 10 would need
to undergo cyclisation to the N-carboxyanhydride 11, which
would then aﬀord the gaburedins via ring opening with amino
acids (note, however, that this would involve nucleophilic attack
at the less electrophilic carbonyl group of 11, which is chemi-
cally unlikely). On the other hand, the carbamoyl adenylate 12
could react with the appropriate amino acids either directly, or
via anhydride 11, to form the gaburedins. Deletion of gbnB in
the gbnR mutant of S. venezuelae abolished gaburedin produc-
tion (Fig. 2), consistent with the key role proposed for GbnB in
gaburedin biosynthesis. GbnA and GbnB appear to be the only
two enzymes required for gaburedin biosynthesis. GbnC isChem. Sci.
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View Article Onlineproposed to export either the gaburedins or intermediate 11/12,
which could react with amino acids in the extracellular milieu to
form the gaburedins.
A handful of other urea-containing natural products are
known, such as the syringolins and the pacidamycins.20–22
Interestingly, the adenylation domain of SylC, which has
been shown to catalyze urea formation in syringolin biosyn-
thesis, shares 39% similarity and 22% identity with GbnB.20
The mechanism for SylC-catalyzed urea formation has been
proposed to involve a ve-membered cyclic N-carboxyanhy-
dride, or a closely related species.20 This anhydride is
hypothesized to be formed via an analogous mechanism to
that suggested for the formation of 11 (Scheme 1). Trapping
of the anhydride with an isoleucyl or valinyl acyl carrier
protein thioester would lead to formation of the ureido
linkage of the syringolins. As noted above, an analogous
mechanism for the formation of the gaburedins via inter-
mediate 11 seems unlikely. Thus, further experiments are
required to establish whether similar or distinct mechanisms
are utilized for urea formation in syringolin and gaburedin
biosynthesis.
Interestingly, BLAST searches revealed analogous operons to
the gbnABC operon in other bacteria such as Streptococcus
mutans, Salmonella enterica and Vibrio vulnicus (see ESI†).
Surprisingly, most of these are clinical isolates of opportunistic
pathogens. It will be important, therefore, to establish the
nature of the metabolites produced by these strains and to
investigate the role of gaburedins and related molecules in
pathogenicity.Conclusions
In summary, bioinformatics analyses suggested that expression
of the gbnABC gene is controlled by the putative pathway-
specic transcriptional repressor GbnR in S. venezuelae. Inac-
tivation of gbnR resulted in derepression of the gbn gene cluster,
resulting in the discovery of the gaburedins, a novel class of
urea natural products. To the best of our knowledge, this is the
rst report of novel natural product discovery via rational
manipulation of a pathway specic transcriptional repressor
gene, an approach that oﬀers considerable potential for acti-
vation of silent biosynthetic pathways in Streptomyces species,
which could lead to the discovery of a wide variety of new
metabolites.Acknowledgements
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